Rosemary Cummins, is a rated equity research analyst with 20 experience specialising in Healthcare research at Citigroup and UBS; together with a focus on global plasma products. She has been a consultant to several Australian and international companies and has also led the Investor Relations function for ASX100 listed pharmacy distribution and hospital companies. Rosemary Cummins is an authorised representative of Anthos Consulting Pty Ltd, which is an authorised representative of MST Financial.